| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | FLII MYH2 MYO7A MYO7B SYNE1 MYO1B IQGAP1 FHOD1 PLEC MYO15A PICK1 | 6.34e-06 | 227 | 178 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.10e-05 | 38 | 178 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.12e-05 | 118 | 178 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | fibroblast growth factor receptor binding | 1.22e-04 | 29 | 178 | 4 | GO:0005104 | |
| GeneOntologyMolecularFunction | actin binding | FLII MYH2 VPS18 MYO7A MYO7B SYNE1 MYO1B EPB41L3 IQGAP1 FHOD1 PLEC MYO15A PICK1 | 3.78e-04 | 479 | 178 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | pancreatic polypeptide receptor activity | 4.69e-04 | 4 | 178 | 2 | GO:0001602 | |
| GeneOntologyCellularComponent | axolemma | 2.96e-05 | 21 | 182 | 4 | GO:0030673 | |
| GeneOntologyCellularComponent | myosin complex | 1.62e-04 | 59 | 182 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | spine apparatus membrane | 2.25e-04 | 3 | 182 | 2 | GO:0098897 | |
| GeneOntologyCellularComponent | actin cytoskeleton | FLII MYH2 VPS18 MYO7A MYO7B MYO1B KEAP1 ARHGAP35 IQGAP1 FHOD1 NTN1 PEAK1 MYO15A JAM3 | 5.40e-04 | 576 | 182 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | SYNE1 ZC3H12B APOBEC3B IQGAP1 HELZ2 PABPC1L ZC3H12C CTSG HTT | 6.04e-04 | 269 | 182 | 9 | GO:0036464 |
| GeneOntologyCellularComponent | microvillus | 7.34e-04 | 123 | 182 | 6 | GO:0005902 | |
| GeneOntologyCellularComponent | neuron projection membrane | 7.52e-04 | 82 | 182 | 5 | GO:0032589 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | SYNE1 ZC3H12B APOBEC3B IQGAP1 HELZ2 PABPC1L ZC3H12C CTSG HTT | 9.56e-04 | 287 | 182 | 9 | GO:0035770 |
| GeneOntologyCellularComponent | ubiquitin ligase complex | DCAF1 PCGF1 DCAF4L2 DCAF8 PRAMEF19 PRAMEF20 KEAP1 FBXL4 FBXO10 OTULIN | 1.07e-03 | 352 | 182 | 10 | GO:0000151 |
| GeneOntologyCellularComponent | main axon | 1.09e-03 | 89 | 182 | 5 | GO:0044304 | |
| MousePheno | abnormal ventral commissure morphology | 1.67e-05 | 51 | 150 | 6 | MP:0008220 | |
| MousePheno | abnormal anterior commissure morphology | 1.67e-05 | 51 | 150 | 6 | MP:0008225 | |
| MousePheno | airway basal cell hyperplasia | 1.14e-04 | 2 | 150 | 2 | MP:0011115 | |
| MousePheno | abnormal airway basal cell differentiation | 1.14e-04 | 2 | 150 | 2 | MP:0011114 | |
| MousePheno | abnormal airway basal cell morphology | 1.14e-04 | 2 | 150 | 2 | MP:0011113 | |
| MousePheno | large forehead | 1.14e-04 | 2 | 150 | 2 | MP:0030042 | |
| MousePheno | increased susceptibility to malignant hyperthermia | 1.14e-04 | 2 | 150 | 2 | MP:0020214 | |
| MousePheno | high forehead | 1.14e-04 | 2 | 150 | 2 | MP:0030032 | |
| Domain | Transciption_factor_Maf_fam | 2.67e-07 | 7 | 177 | 4 | IPR024874 | |
| Domain | bZIP_Maf | 5.21e-06 | 13 | 177 | 4 | IPR004826 | |
| Domain | bZIP_Maf | 5.21e-06 | 13 | 177 | 4 | PF03131 | |
| Domain | - | 1.30e-05 | 16 | 177 | 4 | 1.10.880.10 | |
| Domain | Myosin_head_motor_dom | 2.81e-05 | 38 | 177 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.81e-05 | 38 | 177 | 5 | PS51456 | |
| Domain | Myosin_head | 2.81e-05 | 38 | 177 | 5 | PF00063 | |
| Domain | MYSc | 2.81e-05 | 38 | 177 | 5 | SM00242 | |
| Domain | FGF | 4.99e-05 | 22 | 177 | 4 | PF00167 | |
| Domain | HBGF_FGF | 4.99e-05 | 22 | 177 | 4 | PS00247 | |
| Domain | FGF | 4.99e-05 | 22 | 177 | 4 | SM00442 | |
| Domain | Fibroblast_GF_fam | 4.99e-05 | 22 | 177 | 4 | IPR002209 | |
| Domain | P-loop_NTPase | ATP6V1A MYH2 DNAH10 MYO7A MYO7B RAB42 MYO1B ARHGAP35 SLFN14 ATAD2 NLRP3 IQGAP1 EFTUD2 NWD2 RECQL4 HELZ2 CHD6 CHST2 MYO15A DNAH6 CNP | 5.54e-05 | 848 | 177 | 21 | IPR027417 |
| Domain | IQ | 5.72e-05 | 71 | 177 | 6 | PF00612 | |
| Domain | IL-1_fam/FGF_fam | 6.00e-05 | 23 | 177 | 4 | IPR028142 | |
| Domain | MYTH4 | 6.74e-05 | 9 | 177 | 3 | PS51016 | |
| Domain | MyTH4 | 6.74e-05 | 9 | 177 | 3 | SM00139 | |
| Domain | MyTH4_dom | 6.74e-05 | 9 | 177 | 3 | IPR000857 | |
| Domain | MyTH4 | 6.74e-05 | 9 | 177 | 3 | PF00784 | |
| Domain | FNIP_N_dom | 8.93e-05 | 2 | 177 | 2 | IPR028084 | |
| Domain | FNIP_mid_dom | 8.93e-05 | 2 | 177 | 2 | IPR028085 | |
| Domain | FNIP_C_dom | 8.93e-05 | 2 | 177 | 2 | IPR028086 | |
| Domain | FNIP_C | 8.93e-05 | 2 | 177 | 2 | PF14638 | |
| Domain | FNIP_M | 8.93e-05 | 2 | 177 | 2 | PF14637 | |
| Domain | FNIP_N | 8.93e-05 | 2 | 177 | 2 | PF14636 | |
| Domain | FNIP_fam | 8.93e-05 | 2 | 177 | 2 | IPR026156 | |
| Domain | NPY4_rcpt | 8.93e-05 | 2 | 177 | 2 | IPR001933 | |
| Domain | IQ | 1.20e-04 | 81 | 177 | 6 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 2.14e-04 | 90 | 177 | 6 | IPR000048 | |
| Domain | IQ | 2.57e-04 | 93 | 177 | 6 | PS50096 | |
| Domain | - | 2.74e-04 | 222 | 177 | 9 | 1.25.10.10 | |
| Domain | Cytokine_IL1-like | 3.62e-04 | 36 | 177 | 4 | IPR008996 | |
| Domain | TF_DNA-bd | 4.03e-04 | 37 | 177 | 4 | IPR008917 | |
| Domain | Lys_sp_deMease-like_dom | 5.29e-04 | 4 | 177 | 2 | IPR013637 | |
| Domain | PLU-1 | 5.29e-04 | 4 | 177 | 2 | PF08429 | |
| Domain | - | ATP6V1A DNAH10 MYO7A MYO7B RAB42 ARHGAP35 SLFN14 ATAD2 EFTUD2 NWD2 RECQL4 HELZ2 CHD6 CHST2 MYO15A DNAH6 CNP | 7.52e-04 | 746 | 177 | 17 | 3.40.50.300 |
| Domain | GDNF_rcpt | 8.76e-04 | 5 | 177 | 2 | IPR003438 | |
| Domain | zf-C5HC2 | 8.76e-04 | 5 | 177 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 8.76e-04 | 5 | 177 | 2 | IPR004198 | |
| Domain | FERM_M | 9.33e-04 | 46 | 177 | 4 | PF00373 | |
| Domain | ARM-like | 1.12e-03 | 270 | 177 | 9 | IPR011989 | |
| Domain | FERM_central | 1.18e-03 | 49 | 177 | 4 | IPR019748 | |
| Domain | FERM_domain | 1.18e-03 | 49 | 177 | 4 | IPR000299 | |
| Domain | FERM_1 | 1.28e-03 | 50 | 177 | 4 | PS00660 | |
| Domain | FERM_2 | 1.28e-03 | 50 | 177 | 4 | PS00661 | |
| Domain | FERM_3 | 1.28e-03 | 50 | 177 | 4 | PS50057 | |
| Domain | Band_41_domain | 1.28e-03 | 50 | 177 | 4 | IPR019749 | |
| Domain | B41 | 1.28e-03 | 50 | 177 | 4 | SM00295 | |
| Domain | Pectin_lyas_fold | 1.31e-03 | 6 | 177 | 2 | IPR012334 | |
| Domain | GDNF | 1.31e-03 | 6 | 177 | 2 | PF02351 | |
| Domain | - | 1.31e-03 | 6 | 177 | 2 | 2.160.20.10 | |
| Domain | DUF3398 | 1.31e-03 | 6 | 177 | 2 | PF11878 | |
| Domain | GDNF | 1.31e-03 | 6 | 177 | 2 | SM00907 | |
| Domain | GDNF/GAS1 | 1.31e-03 | 6 | 177 | 2 | IPR016017 | |
| Domain | DOCK_C/D_N | 1.31e-03 | 6 | 177 | 2 | IPR021816 | |
| Domain | BRLZ | 1.48e-03 | 52 | 177 | 4 | SM00338 | |
| Domain | Rho_GTPase_activation_prot | 1.50e-03 | 88 | 177 | 5 | IPR008936 | |
| Domain | BZIP_BASIC | 1.59e-03 | 53 | 177 | 4 | PS00036 | |
| Domain | BZIP | 1.59e-03 | 53 | 177 | 4 | PS50217 | |
| Domain | bZIP | 1.70e-03 | 54 | 177 | 4 | IPR004827 | |
| Domain | RNase_Zc3h12a | 1.82e-03 | 7 | 177 | 2 | PF11977 | |
| Domain | RNase_Zc3h12_NYN | 1.82e-03 | 7 | 177 | 2 | IPR021869 | |
| Domain | Pectin_lyase_fold/virulence | 2.41e-03 | 8 | 177 | 2 | IPR011050 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2 | 1.69e-05 | 17 | 134 | 4 | MM15234 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2 | 2.15e-05 | 18 | 134 | 4 | M27508 | |
| Pathway | REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION | 2.15e-05 | 18 | 134 | 4 | MM14724 | |
| Pathway | BIOCARTA_ARENRF2_PATHWAY | 3.36e-05 | 20 | 134 | 4 | M14339 | |
| Pathway | REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION | 3.36e-05 | 20 | 134 | 4 | M27062 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR2 | 4.12e-05 | 21 | 134 | 4 | MM15242 | |
| Pathway | BIOCARTA_ARENRF2_PATHWAY | 5.00e-05 | 22 | 134 | 4 | MM1449 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR2 | 5.00e-05 | 22 | 134 | 4 | MM15240 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR2 | 6.01e-05 | 23 | 134 | 4 | M27514 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR2_SIGNALING | 6.01e-05 | 23 | 134 | 4 | MM15243 | |
| Pathway | WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1 | 6.77e-05 | 9 | 134 | 3 | M39481 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR2_SIGNALING | 8.46e-05 | 25 | 134 | 4 | M27517 | |
| Pathway | WP_ETHANOL_METABOLISM_RESULTING_IN_PRODUCTION_OF_ROS_BY_CYP2E1 | 9.60e-05 | 10 | 134 | 3 | MM15821 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2 | 1.34e-04 | 28 | 134 | 4 | MM15241 | |
| Pathway | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | 1.74e-04 | 12 | 134 | 3 | MM14728 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2 | 1.77e-04 | 30 | 134 | 4 | M27515 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 2.01e-04 | 31 | 134 | 4 | M47396 | |
| Pathway | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | 2.24e-04 | 13 | 134 | 3 | M1087 | |
| Pathway | REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION | 2.24e-04 | 13 | 134 | 3 | M27061 | |
| Pathway | REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION | 2.24e-04 | 13 | 134 | 3 | MM14723 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 2.58e-04 | 33 | 134 | 4 | MM15252 | |
| Pathway | REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION | 2.58e-04 | 33 | 134 | 4 | M27049 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 2.71e-04 | 94 | 134 | 6 | MM15598 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 2.90e-04 | 34 | 134 | 4 | M27527 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 3.25e-04 | 35 | 134 | 4 | M47379 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 3.25e-04 | 63 | 134 | 5 | M635 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4 | 3.51e-04 | 15 | 134 | 3 | M27509 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4 | 3.51e-04 | 15 | 134 | 3 | MM15235 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1 | 4.30e-04 | 16 | 134 | 3 | M48007 | |
| Pathway | WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS | 4.30e-04 | 16 | 134 | 3 | M42567 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1 | 4.30e-04 | 16 | 134 | 3 | MM15233 | |
| Pathway | REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION | 5.18e-04 | 17 | 134 | 3 | MM17066 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 5.18e-04 | 17 | 134 | 3 | MM15244 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 6.02e-04 | 41 | 134 | 4 | MM14505 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 6.17e-04 | 18 | 134 | 3 | M27518 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR3 | 6.17e-04 | 18 | 134 | 3 | M27521 | |
| Pathway | REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION | 6.17e-04 | 18 | 134 | 3 | M1092 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR3 | 6.17e-04 | 18 | 134 | 3 | MM15247 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 6.94e-04 | 155 | 134 | 7 | M41808 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE | 7.23e-04 | 43 | 134 | 4 | M27534 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 7.28e-04 | 19 | 134 | 3 | MM15250 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 7.28e-04 | 19 | 134 | 3 | MM15245 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 7.75e-04 | 76 | 134 | 5 | MM15442 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 8.32e-04 | 116 | 134 | 6 | MM15715 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 8.50e-04 | 20 | 134 | 3 | M27519 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR4 | 8.50e-04 | 20 | 134 | 3 | M27525 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 8.50e-04 | 20 | 134 | 3 | M27524 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR4 | 8.50e-04 | 20 | 134 | 3 | MM15251 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR1 | 8.50e-04 | 20 | 134 | 3 | MM15237 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 8.60e-04 | 45 | 134 | 4 | M47670 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR1 | 9.85e-04 | 21 | 134 | 3 | M27512 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR1 | 9.85e-04 | 21 | 134 | 3 | M27511 | |
| Pathway | REACTOME_PI_3K_CASCADE_FGFR1 | 9.85e-04 | 21 | 134 | 3 | MM15238 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR4_SIGNALING | 9.85e-04 | 21 | 134 | 3 | MM15248 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 1.01e-03 | 47 | 134 | 4 | MM14885 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 1.09e-03 | 82 | 134 | 5 | M1021 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 1.10e-03 | 48 | 134 | 4 | M26916 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 1.10e-03 | 48 | 134 | 4 | MM15441 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR4_SIGNALING | 1.13e-03 | 22 | 134 | 3 | M27522 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR1_SIGNALING | 1.13e-03 | 22 | 134 | 3 | MM15239 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 1.16e-03 | 83 | 134 | 5 | M27163 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR1_SIGNALING | 1.29e-03 | 23 | 134 | 3 | M27513 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CHRNA7_E2F_SIGNALING_PATHWAY | 1.31e-03 | 6 | 134 | 2 | M47788 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3 | 1.47e-03 | 24 | 134 | 3 | MM15246 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3 | 1.66e-03 | 25 | 134 | 3 | M27520 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 1.71e-03 | 54 | 134 | 4 | M27168 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 1.71e-03 | 54 | 134 | 4 | M620 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 1.83e-03 | 7 | 134 | 2 | M47805 | |
| Pathway | REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION | 1.83e-03 | 7 | 134 | 2 | M27064 | |
| Pathway | REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION | 1.83e-03 | 7 | 134 | 2 | MM14726 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 1.83e-03 | 55 | 134 | 4 | M47952 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4 | 1.86e-03 | 26 | 134 | 3 | MM15249 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4 | 2.08e-03 | 27 | 134 | 3 | M27523 | |
| Pathway | REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION | 2.42e-03 | 8 | 134 | 2 | M27325 | |
| Pathway | REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION | 2.42e-03 | 8 | 134 | 2 | MM15045 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 2.56e-03 | 29 | 134 | 3 | M27528 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 2.56e-03 | 29 | 134 | 3 | MM15253 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1 | 2.83e-03 | 30 | 134 | 3 | MM15236 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR2 | 2.84e-03 | 62 | 134 | 4 | MM15256 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 3.09e-03 | 150 | 134 | 6 | M39520 | |
| Pathway | REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION | 3.11e-03 | 31 | 134 | 3 | M661 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1 | 3.11e-03 | 31 | 134 | 3 | M27510 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 3.11e-03 | 31 | 134 | 3 | M27529 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 3.11e-03 | 31 | 134 | 3 | MM15254 | |
| Pubmed | 3.69e-09 | 5 | 183 | 4 | 16135796 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLII TMEM120B ITPRIPL2 MYO7A DOCK9 TSNARE1 POMGNT1 ARHGAP35 FHIP1B ATP13A2 RYR1 SIL1 BAP1 PNPLA6 DOK4 HELZ2 RIPOR1 MAFF PLEC DOCK6 RGL2 PICK1 ZNF687 HTT | 4.74e-09 | 1105 | 183 | 24 | 35748872 |
| Pubmed | Embryonic lethality and fetal liver apoptosis in mice lacking all three small Maf proteins. | 1.43e-07 | 3 | 183 | 3 | 22158967 | |
| Pubmed | Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks. | 1.43e-07 | 3 | 183 | 3 | 22965115 | |
| Pubmed | 1.43e-07 | 3 | 183 | 3 | 24849809 | ||
| Pubmed | 5.71e-07 | 4 | 183 | 3 | 28941191 | ||
| Pubmed | 5.71e-07 | 4 | 183 | 3 | 9224592 | ||
| Pubmed | Small Maf proteins interact with the human transcription factor TCF11/Nrf1/LCR-F1. | 5.71e-07 | 4 | 183 | 3 | 8932385 | |
| Pubmed | 5.71e-07 | 4 | 183 | 3 | 15087497 | ||
| Pubmed | Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. | 5.71e-07 | 4 | 183 | 3 | 8107826 | |
| Pubmed | 5.71e-07 | 4 | 183 | 3 | 8816476 | ||
| Pubmed | 1.21e-06 | 102 | 183 | 7 | 11214970 | ||
| Pubmed | FLII DCAF8 COPB1 SYNE1 TAF1C ZMYM2 LMO3 PIAS2 IQGAP1 STAB1 RNF123 ARRB1 TTC7B TMEM168 LMO2 CHD6 SUMO3 PLEC CADPS2 CARS2 PICK1 ZNF292 | 1.26e-06 | 1285 | 183 | 22 | 35914814 | |
| Pubmed | 1.42e-06 | 5 | 183 | 3 | 25896808 | ||
| Pubmed | Erythroid maturation and globin gene expression in mice with combined deficiency of NF-E2 and nrf-2. | 1.42e-06 | 5 | 183 | 3 | 9558405 | |
| Pubmed | FLII ATP6V1A VPS18 COPB1 MYO7A SYNE1 SH3KBP1 TPGS1 BCAN ARHGAP35 EPB41L3 IQGAP1 SACM1L NWD2 PNPLA6 TTC7B SPON1 HADHA PEAK1 PLEC VPS51 DNAH6 CNP | 2.06e-06 | 1431 | 183 | 23 | 37142655 | |
| Pubmed | Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. | 2.70e-06 | 19 | 183 | 4 | 16597617 | |
| Pubmed | 2.83e-06 | 6 | 183 | 3 | 11025215 | ||
| Pubmed | 2.83e-06 | 6 | 183 | 3 | 33897412 | ||
| Pubmed | The Bach Family of Transcription Factors: A Comprehensive Review. | 2.83e-06 | 6 | 183 | 3 | 27052415 | |
| Pubmed | 4.94e-06 | 7 | 183 | 3 | 23737527 | ||
| Pubmed | Fgf16 is required for cardiomyocyte proliferation in the mouse embryonic heart. | 4.94e-06 | 7 | 183 | 3 | 18816849 | |
| Pubmed | 4.94e-06 | 7 | 183 | 3 | 11212352 | ||
| Pubmed | 5.04e-06 | 22 | 183 | 4 | 26748348 | ||
| Pubmed | 6.07e-06 | 23 | 183 | 4 | 14517998 | ||
| Pubmed | 6.07e-06 | 23 | 183 | 4 | 23322300 | ||
| Pubmed | 6.07e-06 | 23 | 183 | 4 | 20713518 | ||
| Pubmed | 7.87e-06 | 8 | 183 | 3 | 34061311 | ||
| Pubmed | 7.87e-06 | 8 | 183 | 3 | 11036080 | ||
| Pubmed | FGF signaling directs a center-to-pole expansion of tubulogenesis in mouse testis differentiation. | 8.61e-06 | 25 | 183 | 4 | 20040496 | |
| Pubmed | Expression of Fgf signalling pathway related genes during palatal rugae development in the mouse. | 1.01e-05 | 26 | 183 | 4 | 20348033 | |
| Pubmed | Poly(ADP-ribose) polymerase-1 modulates Nrf2-dependent transcription. | 1.01e-05 | 26 | 183 | 4 | 24140708 | |
| Pubmed | The protomap is propagated to cortical plate neurons through an Eomes-dependent intermediate map. | 1.08e-05 | 94 | 183 | 6 | 23431145 | |
| Pubmed | 1.18e-05 | 27 | 183 | 4 | 19544582 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | MAFG DCAF1 CDKN1C DCAF8 COPB1 MAFK SYNE1 SH3KBP1 ZMYM2 CEP76 TUBGCP4 BAP1 IQGAP1 EFTUD2 ARRB1 RECQL4 SMARCD2 MAFF HADHA | 1.23e-05 | 1155 | 183 | 19 | 20360068 |
| Pubmed | 1.59e-05 | 29 | 183 | 4 | 21876757 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLII RBBP6 KDM5C ZMYM2 ARHGAP35 ATAD2 BAP1 IQGAP1 EFTUD2 PNPLA6 FHOD1 HELZ2 RIPOR1 PLEC ZNF687 | 1.65e-05 | 774 | 183 | 15 | 15302935 |
| Pubmed | 1.67e-05 | 10 | 183 | 3 | 15621532 | ||
| Pubmed | 1.67e-05 | 10 | 183 | 3 | 25912421 | ||
| Pubmed | PICK-1: a scaffold protein that interacts with Nectins and JAMs at cell junctions. | 1.67e-05 | 10 | 183 | 3 | 15811349 | |
| Pubmed | Cholinergic signals preserve haematopoietic stem cell quiescence during regenerative haematopoiesis. | 1.67e-05 | 10 | 183 | 3 | 35087060 | |
| Pubmed | CEP104 ATP6V1A DOCK9 SH3KBP1 BCAN EPB41L3 HCN2 XKR4 PLEC HTT | 1.69e-05 | 347 | 183 | 10 | 17114649 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MRPL20 RBBP6 SYNE1 ZMYM2 MYO1B ARHGAP35 EPB41L3 SACM1L EFTUD2 ZSCAN29 NWD2 HELZ2 CHD6 HADHA PLEC DOCK6 PLXNB1 ZNF292 | 1.81e-05 | 1082 | 183 | 18 | 38697112 |
| Pubmed | 1.94e-05 | 62 | 183 | 5 | 19367581 | ||
| Pubmed | 2.09e-05 | 31 | 183 | 4 | 16123981 | ||
| Pubmed | A cholinergic neuroskeletal interface promotes bone formation during postnatal growth and exercise. | 2.29e-05 | 11 | 183 | 3 | 35276096 | |
| Pubmed | CEP104 KDM5C KEAP1 GINS1 BAP1 IQGAP1 STAB1 ROBO2 CEP126 DOCK6 PLXNB1 ZNF687 | 2.63e-05 | 529 | 183 | 12 | 14621295 | |
| Pubmed | 2.74e-05 | 225 | 183 | 8 | 12168954 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 38070724 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 34453977 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 26999808 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 27129924 | ||
| Pubmed | Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice. | 2.75e-05 | 2 | 183 | 2 | 23521765 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 28258105 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 19344760 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 29114104 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 33995108 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 32552811 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 24836856 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 15948184 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 35678315 | ||
| Pubmed | Oligodendrocyte HCN2 Channels Regulate Myelin Sheath Length. | 2.75e-05 | 2 | 183 | 2 | 34341156 | |
| Pubmed | Functional role of alpha7 nicotinic receptor in physiological control of cutaneous homeostasis. | 2.75e-05 | 2 | 183 | 2 | 12628457 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 25157794 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 31202708 | ||
| Pubmed | Prenatal nicotine exposure alters lung function and airway geometry through α7 nicotinic receptors. | 2.75e-05 | 2 | 183 | 2 | 22246862 | |
| Pubmed | Investigation of MYO15A and MYO7A Mutations in Iranian Patients with Nonsyndromic Hearing Loss. | 2.75e-05 | 2 | 183 | 2 | 31997689 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 27471776 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 22688057 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 32028688 | ||
| Pubmed | A human homologue of Drosophila kelch associates with myosin-VIIa in specialized adhesion junctions. | 2.75e-05 | 2 | 183 | 2 | 11921171 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 30429582 | ||
| Pubmed | A transgenic mouse model reveals fast nicotinic transmission in hippocampal pyramidal neurons. | 2.75e-05 | 2 | 183 | 2 | 21501254 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 21368056 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 1400473 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 26937017 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 36603528 | ||
| Pubmed | Activation of α7nAChR Promotes Diabetic Wound Healing by Suppressing AGE-Induced TNF-α Production. | 2.75e-05 | 2 | 183 | 2 | 26650489 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 22848433 | ||
| Pubmed | Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx. | 2.75e-05 | 2 | 183 | 2 | 10441747 | |
| Pubmed | Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. | 2.75e-05 | 2 | 183 | 2 | 16650968 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 35413868 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 24462939 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 29261717 | ||
| Pubmed | Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice. | 2.75e-05 | 2 | 183 | 2 | 18199426 | |
| Pubmed | Stroke-induced activation of the α7 nicotinic receptor increases Pseudomonas aeruginosa lung injury. | 2.75e-05 | 2 | 183 | 2 | 22490926 | |
| Pubmed | Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus. | 2.75e-05 | 2 | 183 | 2 | 16416087 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 23270857 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 18077004 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 19462340 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 16923147 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 11790782 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 15937072 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 37746145 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 19631623 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 15770102 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 24326163 | ||
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 23811428 | ||
| Pubmed | Alpha 7 subunit of nAChR regulates migration of human mesenchymal stem cells. | 2.75e-05 | 2 | 183 | 2 | 20720594 | |
| Pubmed | 2.75e-05 | 2 | 183 | 2 | 10862778 | ||
| Interaction | CIRBP interactions | 1.30e-05 | 164 | 174 | 9 | int:CIRBP | |
| Interaction | GPRASP2 interactions | 1.39e-05 | 126 | 174 | 8 | int:GPRASP2 | |
| Interaction | MYL6 interactions | DCAF4L2 ESR2 FHIP1B NLRP3 BAP1 IQGAP1 EFTUD2 ARRB1 LMO2 RECQL4 HTT | 1.40e-05 | 255 | 174 | 11 | int:MYL6 |
| Cytoband | 13q11-q12 | 9.43e-05 | 4 | 183 | 2 | 13q11-q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 2.96e-04 | 316 | 183 | 7 | chr3p21 | |
| GeneFamily | A-kinase anchoring proteins|Myosins, class VII|Deafness associated genes|FERM domain containing | 4.59e-05 | 2 | 123 | 2 | 1102 | |
| GeneFamily | Basic leucine zipper proteins | 3.41e-04 | 49 | 123 | 4 | 506 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.69e-04 | 50 | 123 | 4 | 1293 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 3.69e-04 | 50 | 123 | 4 | 721 | |
| Coexpression | CAMPS_COLON_CANCER_COPY_NUMBER_UP | 3.97e-06 | 93 | 182 | 7 | M18750 | |
| Coexpression | E2F3_UP.V1_UP | 7.69e-06 | 190 | 182 | 9 | M2706 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN | 1.12e-05 | 199 | 182 | 9 | M5219 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-06 | 190 | 183 | 8 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 1.40e-06 | 193 | 183 | 8 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-06 | 198 | 183 | 8 | 0b928a829844f49f4d47e88908af192cb919011f | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-06 | 200 | 183 | 8 | 48ce43a27e78b2883e588e1a63fa5352c2deeeb7 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.02e-06 | 171 | 183 | 7 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Prlr_(Entorhinal_cortex?)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.14e-06 | 65 | 183 | 5 | 57d0d892dab8bc8465067feeff279c967a43b781 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Prlr_(Entorhinal_cortex?)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.14e-06 | 65 | 183 | 5 | aba26f607f35c2920cdf956309285ad9e7b758a7 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.47e-06 | 176 | 183 | 7 | 460cb302c5b3d609c65b924e1d4e8ea057a68485 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 182 | 183 | 7 | 7909089ed6325c44edd6f9b7e8b1d542398222ea | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 182 | 183 | 7 | 4a85429d365c4b2d73fc921f261b4b7635ac40bd | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 182 | 183 | 7 | 53213af34af3337f5edc734d3b7b79e4349eac0d | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.35e-05 | 189 | 183 | 7 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.39e-05 | 190 | 183 | 7 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-05 | 195 | 183 | 7 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-05 | 195 | 183 | 7 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-05 | 195 | 183 | 7 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-05 | 195 | 183 | 7 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.70e-05 | 196 | 183 | 7 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-05 | 198 | 183 | 7 | c7dbf24caae5c4ef285845d13055de9e07281bb3 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-05 | 199 | 183 | 7 | 1413156b7be5373fd02bbe39ec50ccfe165fa6d1 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 183 | 7 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.04e-05 | 145 | 183 | 6 | ac41c6c02b7d78162b86222983688f54d04ac47d | |
| ToppCell | MS-CD4-CD8_1|MS / Condition, Cell_class and T cell subcluster | 3.67e-05 | 150 | 183 | 6 | 7dc95c58b98d8c4c6c49fb1a03ec6ac24fb41f54 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.57e-05 | 156 | 183 | 6 | 895927228c93cd090303984c5be6ebfb59ed6f3a | |
| ToppCell | Influenza_Severe-CD4+_T_naive|Influenza_Severe / Disease group and Cell class | 4.74e-05 | 157 | 183 | 6 | 287bdc4e455cd0160261a93d13538e0def49fcd4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-05 | 159 | 183 | 6 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-05 | 159 | 183 | 6 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-05 | 159 | 183 | 6 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.26e-05 | 160 | 183 | 6 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.64e-05 | 162 | 183 | 6 | 19395bdb282b4a2d88cd33191af12c24a88c3d16 | |
| ToppCell | severe-unassigned|World / disease stage, cell group and cell class | 6.04e-05 | 164 | 183 | 6 | b3a45c150df6594debeeca400cc58d30ef662756 | |
| ToppCell | severe-unassigned|severe / disease stage, cell group and cell class | 6.24e-05 | 165 | 183 | 6 | f9ddd547992fec065d539a1d0305acba8fc7d79c | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.90e-05 | 168 | 183 | 6 | 80233a13135fd159f5764336a1fe67fba237776b | |
| ToppCell | BAL-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 6.90e-05 | 168 | 183 | 6 | 65ec473cff748b334c0a66e33bc34a8465fe7631 | |
| ToppCell | COVID-19_Severe-CD4+_CTL|World / disease group, cell group and cell class | 7.13e-05 | 169 | 183 | 6 | 8c8168ac93a808d7b4756e4491db2b2979df1c1f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.37e-05 | 170 | 183 | 6 | 67415b098e8ba815b501e557192a9f2b10ee995a | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-05 | 173 | 183 | 6 | cc094992b8027f4cef38f0fb0b76f0d07210d1e2 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-05 | 173 | 183 | 6 | a5b6c3d58f7a8e533330798b81496009a31548af | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 174 | 183 | 6 | 0cf40ce9d9ad926c4909665aaa224694b5d970cb | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 8.37e-05 | 174 | 183 | 6 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 9.20e-05 | 177 | 183 | 6 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.49e-05 | 178 | 183 | 6 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.01e-04 | 180 | 183 | 6 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-04 | 181 | 183 | 6 | 2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c | |
| ToppCell | AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.04e-04 | 181 | 183 | 6 | ed0ea67f0607073aedf153f8d1073b35e46127c3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 181 | 183 | 6 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.07e-04 | 182 | 183 | 6 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 183 | 183 | 6 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-04 | 183 | 183 | 6 | 89727b4f65949ed2dce9d2e0228c79fe4280230c | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 183 | 183 | 6 | 19e7be1cfdd111bfb840532a6f7c780345dffccf | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 183 | 183 | 6 | b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0 | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-04 | 183 | 183 | 6 | 113e6d8d4bb271be984af06cd6c22b180425dcfc | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.14e-04 | 184 | 183 | 6 | 92202e1cd0bba1ce4b061ebcb8a2af5bb590542a | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 184 | 183 | 6 | 89ac32e374a4379e4a6c6ea7603b1378b77c147f | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 184 | 183 | 6 | 4df6027fa635996c1eddb920f88a5265772df1cd | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.14e-04 | 184 | 183 | 6 | 337e38a6b2b6770cc992d88b006829f194841b10 | |
| ToppCell | BAL-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.14e-04 | 184 | 183 | 6 | 7331535d469453a5264dcb0270a97f63d3b55201 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 185 | 183 | 6 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 185 | 183 | 6 | d4ba36bdb8b7e3a62e827269484f89f790eaa5ef | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 185 | 183 | 6 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 185 | 183 | 6 | 6938ac3cab536cf8a474eba441ce6dcdfcc43b53 | |
| ToppCell | droplet-Lung-nan-21m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 185 | 183 | 6 | 0e7351cd6d6e6e8c29573042e168da50ee496cfc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-04 | 186 | 183 | 6 | bdbe290f81106a53c8c30a92fbb385597c62b2ac | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 189 | 183 | 6 | 1137583e21d874c201c20581ba1995e2bfa3de59 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 190 | 183 | 6 | 7068754c29f63a331e2b6c54715f3b26f37ad32b | |
| ToppCell | Control-Myeloid-transitional_Macro|Control / Disease group,lineage and cell class （2021.01.30） | 1.39e-04 | 191 | 183 | 6 | 3ed0b1ff628a165e3c92c2e493206015f57dccfe | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 1.39e-04 | 191 | 183 | 6 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.43e-04 | 192 | 183 | 6 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | Ciliated-cil-3|World / Class top | 1.43e-04 | 192 | 183 | 6 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 1.48e-04 | 193 | 183 | 6 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 1.48e-04 | 193 | 183 | 6 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.48e-04 | 193 | 183 | 6 | d7750a7575ef257963b7f1c64fa67c52dbff797b | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-04 | 193 | 183 | 6 | 8d05805295c5d3aa93aeb38be5fbefa81e1be1f0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-04 | 193 | 183 | 6 | 1b2cc627b2aa002b442358bd1188d470e67ce7d9 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.48e-04 | 193 | 183 | 6 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.52e-04 | 194 | 183 | 6 | f2f7b9aad7588c8020a4850ff9333e1db8eafac7 | |
| ToppCell | ILEUM-inflamed-(3)_moDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.52e-04 | 194 | 183 | 6 | c9d2acab0bbcfa9a9113cf3b9f8147403f0beb43 | |
| ToppCell | PND07-28-samps-Mesenchymal|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.52e-04 | 194 | 183 | 6 | 68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-04 | 194 | 183 | 6 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.52e-04 | 194 | 183 | 6 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 195 | 183 | 6 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 195 | 183 | 6 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 195 | 183 | 6 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-04 | 195 | 183 | 6 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 195 | 183 | 6 | ce8215d503cad3a9bc7d5d2be4adb57408015593 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-04 | 195 | 183 | 6 | 67b05a0cd2ca9924eca81a92cc6330eecb9d963c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 195 | 183 | 6 | 37aa6e4123d37de4de42ca68d3020f2a7686ce02 | |
| ToppCell | severe_COVID-19-Non-classical_Monocyte|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.60e-04 | 196 | 183 | 6 | 34c1c74cad5e23196e86cfd6f19c836fe57b2264 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-04 | 196 | 183 | 6 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| ToppCell | ILEUM-inflamed-(3)_Resident_macrophages|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.60e-04 | 196 | 183 | 6 | 5ac246a823a8e1996325753858615269687b429d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-04 | 196 | 183 | 6 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 196 | 183 | 6 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | E17.5-Mesenchymal|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.60e-04 | 196 | 183 | 6 | b4ee991445b612506372b9361ebfe72cb59b811e | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.60e-04 | 196 | 183 | 6 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-04 | 196 | 183 | 6 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | Caecum-T_cell-Tfh|T_cell / Region, Cell class and subclass | 1.60e-04 | 196 | 183 | 6 | fe2ee5788028e6b671674f0cc50e2b6379f50976 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-04 | 196 | 183 | 6 | f429f045ba45e24717963315832150b12a115bfa | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.60e-04 | 196 | 183 | 6 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.65e-04 | 197 | 183 | 6 | a357ee2ba9100dfaeba9ecae8138a2776bb54b0b | |
| ToppCell | distal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.65e-04 | 197 | 183 | 6 | 52e9dc35dd8cc2605fa4894bb16bb5c6086faa76 | |
| Disease | X-13844 measurement | 3.38e-05 | 2 | 172 | 2 | EFO_0800744 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.08e-04 | 128 | 172 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.08e-04 | 128 | 172 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.08e-04 | 128 | 172 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.08e-04 | 128 | 172 | 6 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.08e-04 | 128 | 172 | 6 | C0007134 | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 2.01e-04 | 4 | 172 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | Globozoospermia | 2.01e-04 | 4 | 172 | 2 | C0403825 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.39e-04 | 148 | 172 | 6 | C0279702 | |
| Disease | cognitive disorder (implicated_via_orthology) | 4.99e-04 | 6 | 172 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | spondin-1 measurement | 4.99e-04 | 6 | 172 | 2 | EFO_0008290 | |
| Disease | rheumatoid arthritis (biomarker_via_orthology) | 4.99e-04 | 6 | 172 | 2 | DOID:7148 (biomarker_via_orthology) | |
| Disease | blindness (implicated_via_orthology) | 9.24e-04 | 8 | 172 | 2 | DOID:1432 (implicated_via_orthology) | |
| Disease | pelvic organ prolapse | 1.24e-03 | 136 | 172 | 5 | EFO_0004710 | |
| Disease | heparin-binding egf-like growth factor measurement | 1.47e-03 | 10 | 172 | 2 | EFO_0020438 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.65e-03 | 291 | 172 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | aortic valve stenosis (is_marker_for) | 1.79e-03 | 11 | 172 | 2 | DOID:1712 (is_marker_for) | |
| Disease | nicotine dependence (implicated_via_orthology) | 2.15e-03 | 12 | 172 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Abnormality of the dentition | 2.15e-03 | 12 | 172 | 2 | HP_0000164 | |
| Disease | Congenital muscular dystrophy | 2.15e-03 | 12 | 172 | 2 | cv:C0699743 | |
| Disease | Neurobehavioral Manifestations | 2.15e-03 | 12 | 172 | 2 | C0525041 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 2.31e-03 | 45 | 172 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 2.31e-03 | 45 | 172 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | mean fractional anisotropy measurement | 2.35e-03 | 95 | 172 | 4 | EFO_0008399 | |
| Disease | Manganese Poisoning | 2.94e-03 | 14 | 172 | 2 | C0677050 | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 2.94e-03 | 14 | 172 | 2 | cv:C2931907 | |
| Disease | sulfate measurement | 2.94e-03 | 14 | 172 | 2 | EFO_0007864 | |
| Disease | vitamin D measurement, COVID-19 | 2.95e-03 | 49 | 172 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | lateral ventricle volume change measurement | 3.37e-03 | 15 | 172 | 2 | EFO_0021502 | |
| Disease | Prostatic Neoplasms | ESR2 KEAP1 SIL1 BAP1 RNASE4 SLC22A3 ROBO2 CHD6 DNASE1L2 ZNF292 | 3.43e-03 | 616 | 172 | 10 | C0033578 |
| Disease | Malignant neoplasm of prostate | ESR2 KEAP1 SIL1 BAP1 RNASE4 SLC22A3 ROBO2 CHD6 DNASE1L2 ZNF292 | 3.43e-03 | 616 | 172 | 10 | C0376358 |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 3.84e-03 | 16 | 172 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | DOCK9 LMO3 BCAN ARHGAP35 ATP13A2 GINS1 EFTUD2 ARHGAP22 GJD3 ROBO2 NTN1 PLEC PICK1 HTT | 4.09e-03 | 1069 | 172 | 14 | EFO_0004346 |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 4.30e-03 | 56 | 172 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | muscular dystrophy (is_implicated_in) | 4.34e-03 | 17 | 172 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 4.34e-03 | 17 | 172 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | Autistic Disorder | 4.40e-03 | 261 | 172 | 6 | C0004352 | |
| Disease | immature platelet fraction | 4.52e-03 | 114 | 172 | 4 | EFO_0009187 | |
| Disease | Drug habituation | 4.67e-03 | 115 | 172 | 4 | C0013170 | |
| Disease | Drug abuse | 4.67e-03 | 115 | 172 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.67e-03 | 115 | 172 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 4.67e-03 | 115 | 172 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 4.67e-03 | 115 | 172 | 4 | C0013222 | |
| Disease | Drug Dependence | 4.67e-03 | 115 | 172 | 4 | C1510472 | |
| Disease | Substance Dependence | 4.67e-03 | 115 | 172 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 4.67e-03 | 115 | 172 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.67e-03 | 115 | 172 | 4 | C0029231 | |
| Disease | Endometrial Neoplasms | 4.75e-03 | 58 | 172 | 3 | C0014170 | |
| Disease | Substance abuse problem | 4.81e-03 | 116 | 172 | 4 | C0740858 | |
| Disease | immature platelet measurement | 5.26e-03 | 119 | 172 | 4 | EFO_0803541 | |
| Disease | insulin sensitivity measurement, body mass index | 5.41e-03 | 19 | 172 | 2 | EFO_0004340, EFO_0004471 | |
| Disease | triglyceride measurement, body mass index | 5.41e-03 | 19 | 172 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.83e-03 | 195 | 172 | 5 | DOID:1574 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YQSLLTRARARGLVC | 166 | P08588 | |
| RYRCKTIGVFRRSNQ | 66 | Q14236 | |
| DVCGRTEIRNYRREV | 231 | Q9UL15 | |
| YRRALCRLSQAGARV | 131 | Q9UH17 | |
| YRGRCDSIQFAVDRR | 406 | Q96KE9 | |
| IYRCRASGIFLRLEG | 481 | Q9UK96 | |
| LRRRQLYCRTGFHLE | 61 | P31371 | |
| DSLLRVDCIRYNRAV | 536 | Q92560 | |
| DVEVRRSCRIRSRYS | 151 | Q6PL18 | |
| VYRNARRAFATCLRS | 601 | Q8TAP6 | |
| ACYDRGRACRSYRVR | 386 | Q8WUJ3 | |
| RRVYVTLTCAFRYGR | 51 | P49407 | |
| CYCIYRLTRGRRRGD | 21 | Q8N2F6 | |
| ILEEVRYIANRFRCQ | 436 | P36544 | |
| DLSGLVRCQRRITVY | 71 | Q96I13 | |
| VRCQRRITVYRNGRL | 76 | Q96I13 | |
| RLQARCRGYLVRQEF | 751 | P46940 | |
| CRGYLVRQEFRSRMN | 756 | P46940 | |
| RLSRDGRYLVYICFR | 1571 | Q9ULI1 | |
| RIACGEKYRVLARRV | 561 | Q9Y483 | |
| RYCVVSERGEERLRS | 76 | O95631 | |
| GRKLCRRDYLRLFGQ | 76 | P25791 | |
| TVGAECYRRALQLRA | 46 | Q8N4Z0 | |
| RFRCITRSFYRNVVG | 76 | Q8N4Z0 | |
| IDRYGRRTAIILSSC | 101 | Q8TD20 | |
| VARALSRSRRYVCAR | 11 | P0C860 | |
| SVFLFVAVRLCRRSR | 651 | Q96TA0 | |
| ASREFQLRLREYLGC | 296 | Q86VZ1 | |
| VDTVLRYRCREGLAQ | 836 | Q96GW7 | |
| YLEYLREARRGVDRC | 551 | Q8N612 | |
| DRSDCTYIVLNGRLR | 661 | Q8IY17 | |
| DTVCRLYEVGRQRLA | 1381 | Q9Y4B6 | |
| VNLRNYLGAECRTVR | 566 | Q13045 | |
| RRTLKNRGYAASCRV | 56 | Q9ULX9 | |
| RRTLKNRGYAASCRV | 56 | O15525 | |
| RRTLKNRGYAASCRI | 56 | O60675 | |
| RERCGYRLVRRQRSA | 221 | Q92731 | |
| LVCYARIYRRLQRQG | 231 | P50391 | |
| RCLRGFFIKRRFRSL | 1911 | Q9UKN7 | |
| YRVSGSRVRVERLCQ | 586 | Q9P107 | |
| VYCRLQGRSQELVRI | 26 | Q9HCQ5 | |
| ACRARRLYVSFREVG | 266 | P27539 | |
| GRQCIEHYRRLRRYC | 616 | Q9BY66 | |
| FLRFANYCRIARELR | 36 | Q8NA75 | |
| SCGYFRETIRRDIRQ | 231 | O95382 | |
| SRAFRAYVSRVCLRD | 241 | O43157 | |
| KCSRRRYQQGLRGRT | 36 | A0A087WWA1 | |
| ARCRGFLARVEYQRM | 796 | Q9UKX2 | |
| FLGRINDCYKRSLER | 176 | Q9H792 | |
| ERARFIRCIYNLLQS | 241 | P53618 | |
| YEACGARVFVQRFRL | 171 | Q5TAQ9 | |
| GYAQACRSKRLQQRR | 171 | P54845 | |
| ILCRRDYLRLFGVTG | 61 | Q8TAP4 | |
| QRARRFCRDNYTDLV | 51 | P14151 | |
| VLNRLCRLGTDYIRF | 41 | Q9UGJ1 | |
| SRLYTVDCRFRERIE | 106 | Q9HCT0 | |
| VRARLECEINTYRGL | 386 | Q92764 | |
| TRRDSALYRCEVVAR | 106 | Q9BX67 | |
| RFRRYLSAGRLVRAQ | 36 | Q9UBC1 | |
| FLFVAVRLCRRSRAA | 706 | Q9Y5E8 | |
| RVCRDVATRRSLGYA | 41 | Q4VXU2 | |
| ILEEVRYIANRFRCQ | 346 | Q494W8 | |
| RRYARTEGNCTALTR | 16 | Q9UBG3 | |
| IRRGERSCYRSINRG | 521 | Q7Z6E9 | |
| RYLNAYTGIVLLRCR | 56 | Q969H6 | |
| RAALCFRRNLGTYNR | 111 | Q9NZK7 | |
| RRVRGDNYCALRATL | 121 | Q96BN8 | |
| YRTEEQGRRLSRECR | 601 | Q92896 | |
| VFTVGRICASRTRIY | 461 | Q8N4S0 | |
| TLYAQSRLRRQGIFC | 481 | Q9NQ11 | |
| RFRRLGYVSLCDNEK | 91 | O60308 | |
| EAKYVVRRACRFALR | 366 | Q9C0G6 | |
| REIVRRGALILFCDY | 1891 | P42858 | |
| AYDRIVACGARLRRS | 246 | Q92874 | |
| LRLAAEQFCTRLGRY | 376 | Q96HP0 | |
| FQTAILRRQGRYICS | 81 | Q9BZ29 | |
| RYRTLRQCLAGRDRN | 56 | O00451 | |
| RLRSEYVAQCLGRAA | 41 | Q9GZZ7 | |
| YRETVQVGRCRLLLA | 91 | P49918 | |
| NDKARRYLRAECFRV | 1086 | Q8TD26 | |
| YICLRRRARTATRGE | 16 | Q9UKA2 | |
| ICRNRARKYFVESNR | 66 | Q9P2H0 | |
| RLSYRRSVCRLLSNF | 266 | Q96SL1 | |
| QIRLIVYQDCERRGR | 41 | Q8TF40 | |
| EIRLIVYQDCDRRGR | 46 | Q9P278 | |
| YCVPRGNRRRFRVRQ | 46 | Q9BXY8 | |
| YLRRQGVCVRTENLA | 351 | P78396 | |
| RRIRLQLYVFVVRCI | 81 | Q86UW7 | |
| DLAAYCRRRDIRILV | 106 | P09543 | |
| YLIIRACARRAQRRS | 211 | P08034 | |
| ACRRAYAAFSVGRRE | 111 | P60827 | |
| ALRARRARRCYLLSV | 126 | Q8N144 | |
| ERQRVRCVNEGYARL | 81 | Q6XD76 | |
| FRILRSRGYICRNFT | 16 | P40939 | |
| DCEQRRFYVQALLRA | 256 | Q14145 | |
| RRLRGRQYLVVADVC | 486 | Q5VTJ3 | |
| RFDLNRSLGIAVYRC | 681 | Q5VTJ3 | |
| VQRDRQCLRIFGSYD | 166 | P08311 | |
| REFALEYRTCRERVL | 981 | Q9Y613 | |
| VVAACYFSRLLRRHR | 1486 | Q9BYK8 | |
| LILRCFRVDRVYRAV | 3831 | Q8IVF4 | |
| ISRRSCFRAGVRYYV | 211 | Q9NTJ5 | |
| RRGRCQRYLLEAAND | 86 | O75751 | |
| LRLYRAVCALGNNRV | 1666 | P21817 | |
| YFGEICLLTRGRRTA | 606 | Q9UL51 | |
| GRRTASVRADTYCRL | 616 | Q9UL51 | |
| CASGLLIYRDRLRIN | 316 | Q9Y2J2 | |
| LCSLRRYGRDATRFT | 181 | Q8TEW6 | |
| RDVLTRACAYQDRRG | 11 | Q96FZ2 | |
| IRSVQLRDRGAYVCV | 471 | Q6UY18 | |
| YVRCSVRAEVRHLRR | 191 | Q9BSM1 | |
| GRRDYTVQVQLRLCL | 201 | O75928 | |
| RSLATVRYSLEGRCR | 261 | Q3MIP1 | |
| RKYVRSRFQCIEDRN | 141 | Q96P20 | |
| HGILRRRQLYCRTGF | 61 | Q9NP95 | |
| GFRKRRQCTFRTFTR | 161 | Q9UBD0 | |
| LAQRGARVYLACRDV | 61 | Q8TC12 | |
| VLSELRRLQNECRGY | 466 | O15211 | |
| EGYCSRILRAQGTRR | 41 | Q9HCB6 | |
| ACSYVRFDIIRRILT | 91 | Q9HA77 | |
| FRGRKNRCYRLAVRT | 31 | Q9BYC9 | |
| NRCYRLAVRTVIRAF | 36 | Q9BYC9 | |
| LRICSLRSNLYRRDV | 121 | P0C7P3 | |
| RLALADDRRYFCRVE | 131 | Q6ZMC9 | |
| NILRLVAYCLRERGA | 76 | O75716 | |
| YQRGCLYRLRALGER | 236 | A0PK00 | |
| ELRRYCQEVFGRVER | 8191 | Q8NF91 | |
| FAFRETREVRGSCRL | 171 | Q14C87 | |
| TDFLCFLEIYQRRRL | 216 | Q17RQ9 | |
| ICDFLYGRVQARERQ | 1051 | O94761 | |
| TARDLLFRGGCRYRK | 81 | Q15572 | |
| RIRFFEGYLDQLIRC | 276 | Q5SWL8 | |
| LNRRRRRFCSKVEGY | 261 | Q8WZA1 | |
| RRRQLYCRTGFHLEI | 61 | O43320 | |
| VYLFFQAGDCRLRRQ | 351 | Q8NGU9 | |
| GERRRRRCQVAFSYL | 96 | Q96B97 | |
| RESYDVRGIVCRSRF | 416 | Q5VT98 | |
| LGVLLTTCRDRYRQD | 401 | Q9H173 | |
| RRGRYLTVACIFRGK | 306 | Q9H4B7 | |
| LRQATVFRCLERYSE | 266 | Q9BXB7 | |
| VLYRTRCTRLGRFAS | 1156 | Q9NRY4 | |
| LLLAARQVRRIVCSY | 101 | Q9BYC2 | |
| LAVTRVYGIQRFCRD | 471 | Q99884 | |
| LRAELCRQRTEYERS | 606 | Q7Z5H3 | |
| TAYFLKRGIRLRCIR | 86 | Q5VYV7 | |
| NRYFRQIFSCGRLRF | 356 | Q92925 | |
| CVGIFRVCIYRRRTN | 51 | H7C241 | |
| QRLARFEEECRKYRT | 286 | Q9Y4C5 | |
| NRRLRAYLAFLFVRE | 161 | Q8NET6 | |
| YCERQGLSMRQIRFR | 46 | P55854 | |
| GLLYAIRCVRRSREF | 166 | Q7Z614 | |
| RYRAIASTRRVVIAC | 121 | P34096 | |
| ARQLGSRYFALVERR | 341 | Q9UID3 | |
| RRGARSYQVICRDEK | 31 | P00750 | |
| RILQAVNALGYCRRD | 166 | Q96NA8 | |
| ARGFLRTLEQCRYRV | 366 | P17040 | |
| ALGFLRTLEQCRYRF | 526 | P17040 | |
| RTLEQCRYRFKNLLR | 531 | P17040 | |
| VCRRLDIYARSVRRQ | 101 | Q5TG30 | |
| RLARRLYHLEGFQRC | 316 | Q9BQI7 | |
| LRRLRRRDSGVYLCA | 631 | Q13214 | |
| TAEERLRRRAYERGC | 476 | Q5XPI4 | |
| LAREADFCFRQRRYL | 426 | Q9P253 | |
| RYVLELLQTRRFCRL | 121 | Q6P2H8 | |
| EGCDRIYATRSNLLR | 2261 | O60281 | |
| FNVKEGRTRCRLFIY | 446 | Q5GH76 | |
| LVCYARIYRRLQRQG | 231 | P0DQD5 | |
| LVFRYHVVGCRRLRS | 1641 | Q9NY15 | |
| RLASFYERAGRVKCL | 381 | P38606 | |
| LCGFLYVRVDGSRLR | 11 | Q9HCK4 | |
| LYRGRICRRLSVVFA | 256 | Q9H0V1 | |
| RLSYTQLLRRCRRDD | 3991 | Q15149 | |
| VQGRRVVCYDDRFIV | 271 | Q5HYM0 | |
| LYKQDFARRLGLRCV | 711 | Q9UBW7 | |
| LTRRARVYSGENIFC | 306 | Q86TV6 | |
| LREACLHVSRRVGYR | 751 | Q8N1G0 | |
| LAREIFRRHFRQLCY | 46 | O15535 | |
| VQGRRVVCYDDRFIV | 326 | Q9C0D7 | |
| LREYGFLRTLEQCRT | 286 | Q8IWY8 | |
| DCVSAVYTVLARRRG | 841 | Q15029 | |
| RNRRCTVAYLYDRLL | 71 | Q14691 | |
| GQDVRCRRLVREGTY | 311 | Q8WUA8 | |
| LYEAYCVQRRLRDGA | 146 | Q6ZS17 | |
| RTYSELLRRICRDGQ | 141 | Q6ZTW0 | |
| RVSTGNYEYRLILRC | 286 | Q9NRD5 | |
| CLGRVADVYRYCRVR | 121 | Q86U90 | |
| RCQYVVGRERTELAR | 121 | Q5SQQ9 | |
| GRQCIEHYRRLRRYC | 626 | P41229 | |
| LLENVRVRRAGYAFR | 621 | O43795 | |
| RIIQFQARCRAYLVR | 816 | Q13402 | |
| YCEERLRRTFVNGTR | 1226 | Q13402 | |
| CAERLRRTYANGVRA | 1166 | Q6PIF6 | |
| VLAGIFCYRRRRTFR | 421 | Q9NQS3 |